- Adults establishing cardiovascular risk
- People with premature heart disease in the family, diabetes, high triglycerides or uncertain LDL-based risk
- Anyone whose treatment decision may change with ApoB, Lp(a) or coronary calcium
Standard of care
TEST PASSPORT · REVIEWED JULY 2026
Advanced lipids: ApoB + Lp(a)
Count atherogenic particles, identify inherited Lp(a) risk and put cholesterol in context.A standard lipid panel remains useful. ApoB estimates the number of atherogenic particles; Lp(a) is largely inherited and is generally measured at least once in adulthood under current U.S. guidance.
ACCESSLab drawVenous blood
TURNAROUNDOften 2–5 daysProvider and location dependent
RELATIVE COST$$Total downstream cost matters
COMMERCE STATUSPartner readyAt-home order + local draw + clinician interpretation
HOW TO USE THIS PAGE
Decide whether this test deserves a place in your plan.
- 01Confirm the question
Be clear about what decision the result would change before ordering.
- 02Check fit and preparation
Review who it helps, who should pause and how to protect the quality of the signal.
- 03Plan the response
Know what you will do with a normal, abnormal or unclear result.
01 / WHO SHOULD TAKE IT
Fit the test to
the person.
Testing is useful when the result can change a real decision. These are educational selection criteria, not a diagnosis or personal order.- Chasing an isolated ‘optimal’ number without total risk
- Using a favorable HDL value to cancel elevated ApoB or other risk
02 / SIGNAL VS. STORY
What it tells you.
What it cannot.
01
LDL-C, non-HDL-C, HDL-C and triglycerides
02
ApoB particle burden
03
Lp(a), an inherited risk-enhancing lipoprotein
01
It does not show whether plaque is already present
02
Treatment thresholds depend on total cardiovascular risk and history
03
Lp(a) is not meaningfully lowered by lifestyle alone in most people
03 / MARKERS + RANGES
Read the panel
without chasing flags.
The report should show its own method, units and laboratory reference interval. Clinical decision thresholds may be different from a lab interval. We do not invent a universal “optimal” range where authoritative guidance does not support one.Use the laboratory unit and method, then interpret with symptoms, trend and the decision this marker can change.
Use the laboratory unit and method, then interpret with symptoms, trend and the decision this marker can change.
Use the laboratory unit and method, then interpret with symptoms, trend and the decision this marker can change.
Use the laboratory unit and method, then interpret with symptoms, trend and the decision this marker can change.
Use the laboratory unit and method, then interpret with symptoms, trend and the decision this marker can change.
Use the laboratory unit and method, then interpret with symptoms, trend and the decision this marker can change.
Use the laboratory unit and method, then interpret with symptoms, trend and the decision this marker can change.
MEN, WOMEN + LIFE-STAGE CONTEXT
The correct range is personal context—not pink versus blue numbers.
Where biology differs, we call it out. Clinical interpretation should also reflect organs present, hormone therapy, pregnancy, age, medications and health history.
Pregnancy and menopause can shift lipids; reproductive history can also inform overall cardiovascular risk.
Risk often appears earlier on average, so age, blood pressure, smoking, family history and diabetes remain essential context.
04 / PREPARATION
Protect the quality
of the signal.
The best assay cannot rescue the wrong timing, wrong specimen or wrong question. Follow the ordering clinician and laboratory instructions when they differ from this general guide.Often unnecessary, but a fasting sample can help when triglycerides are high or the clinician requests it.
Avoid testing during an acute illness when possible.
Lp(a) may be reported in nmol/L or mg/dL; they are not reliably interchangeable with a single conversion.
REPEAT CADENCELp(a) is usually once in adulthood unless a specific clinical reason exists. Lipids and ApoB are repeated when risk or treatment changes.
05 / AFTER THE RESULT
Turn the number
into a next step.
- 01
Calculate total risk rather than reading LDL alone
- 02
Discuss lifestyle and medication thresholds based on history and risk
- 03
Consider CAC imaging only when it can resolve a genuinely uncertain decision
DO NOT WAIT ON A CONSUMER TEST
Chest pressure, shortness of breath or symptoms of stroke require emergency care—not a lab order
Very high triglycerides can raise pancreatitis risk and need prompt clinical review
06 / MODERN BIO SELECT
Built for a responsible purchase path.
A high-value commercial pathway because it can change prevention decisions—not because it creates more numbers.Advanced lipids: ApoB + Lp(a)
- Future format
- At-home order + local draw + clinician interpretation
- Price position
- Future Cardiometabolic Deep Dive
- Before checkout
- Eligibility · method · privacy · total cost · interpretation · abnormal-result routing
07 / SCIENTIFIC FOUNDATION